Candel Therapeutics Shares Resumed Trade
Portfolio Pulse from Benzinga Newsdesk
Candel Therapeutics, Inc. shares have resumed trading after a temporary halt. The reason for the halt was not specified in the article.
November 28, 2023 | 2:55 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Candel Therapeutics, Inc. shares have resumed trading. The lack of information on why trading was halted may lead to market speculation and volatility in the short term.
Without specific details on the trading halt, investors may react cautiously, leading to potential short-term volatility in CADL's stock price. However, without more information, it is difficult to predict the direction of the impact.
CONFIDENCE 50
IMPORTANCE 75
RELEVANCE 100